Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christopher L. Harwood"'
Autor:
Patrick G. Sullivan, W. Brad Hubbard, Hemendra J. Vekaria, John G. Geisler, Christopher L. Harwood
Publikováno v:
Journal of Neuroscience Research. 96:1677-1688
Traumatic brain injury (TBI) results in cognitive impairment, which can be long-lasting after moderate to severe TBI. Currently, there are no FDA-approved therapeutics to treat the devastating consequences of TBI and improve recovery. This study util
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae83bec3df52ade5cd358d4089f82895
https://doi.org/10.1002/jnr.24271
https://doi.org/10.1002/jnr.24271
Autor:
Kathryn E. Saatman, Joe E. Springer, Paresh Prajapati, Patrick G. Sullivan, W. Brad Hubbard, Christopher L. Harwood
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
While mitochondria maintain essential cellular functions, such as energy production, calcium homeostasis, and regulating programmed cellular death, they also play a major role in pathophysiology of many neurological disorders. Furthermore, several ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04140096f5da0f3ca350d6dadf51ea62
https://pubmed.ncbi.nlm.nih.gov/31273236
https://pubmed.ncbi.nlm.nih.gov/31273236
Autor:
Brent J. Shelton, Holly Chitwood, Lee Vermuelen, Christopher L. Harwood, Catherine R. Garcia, John L. Villano, Rachael M. Morgan
Publikováno v:
Neuro Oncol
INTRODUCTION Bevacizumab is an antibody against vascular endothelial growth factor that has been well investigated for glioblastoma, however, has limited proven efficacy. The drug has, however, demonstrated survival benefit in non-small cell lung car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2c1857e1354f8b684e3f21c617cb98
https://doi.org/10.1093/neuonc/noz175.317
https://doi.org/10.1093/neuonc/noz175.317